Price (delayed)
$0.38
Market cap
$2.5M
P/E Ratio
0.75
Dividend/share
N/A
EPS
$0.51
Enterprise value
$1.23M
Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Its proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the
There are no recent dividends present for MTEM.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.